Health ❯ Healthcare ❯ Pharmaceuticals ❯ Drug Pricing

Weight Loss Drugs

CMS Pauses Medicare GLP-1 Pilot After Insurers Balk, Sets 2026–27 Bridge

A government-funded bridge will preserve $50 access for beneficiaries.

FDA Clears Lilly’s Foundayo Pill, Escalating GLP-1 Weight-Loss Rivalry

Lilly Cuts Zepbound Cash Prices on LillyDirect as GLP‑1 Price Competition Deepens

Novo Nordisk Lowers Wegovy and Ozempic Cash Price to $349 and Unveils $199 Starter Offer

SNL Recreates Oval Office Collapse to Skewer Trump on Shutdown Fallout

U.S. Strikes Price-Cut Deals With Novo Nordisk and Eli Lilly for GLP‑1s, With Medicare Pilot in 2026

White House Seals Deals With Lilly and Novo to Cut GLP-1 Costs, Pilot Medicare Coverage

Eli Lilly to Raise UK Mounjaro Prices by Up to 170% in September

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves